OBJECTIVE: To study the impact of parity history on the risk of antibodies to citrullinated peptide antigens (ACPA) positive and ACPA-negative rheumatoid arthritis (RA), in different age-groups. METHOD: Data from a population-based case-control study of female incident RA cases were analysed (2035 cases and 2911 controls, aged 18-70 years ). Parity history was assessed through a questionnaire. Parous women were compared with nulliparous, by calculating odds ratios (ORs) with 95% confidence interval (CI). RESULTS: Parity was associated with an increased risk of ACPA-negative RA in women aged 18-44 years (OR=2.1, 95% CI 1.4 to 3.2), but not in those aged 45-70 years (OR=0.9, 95% CI 0.7 to 1.3). Among young women, an increased risk of ACPA-negative RA was found in those who gave birth during the year of symptom onset (OR=2.6, 95% CI 1.4 to 4.8) and who were at a young age at first birth (<23) (OR=2.5, 95% CI 1.5 to 4.1). Parity and the postpartum period were not associated with ACPA-positive RA, but older age at first birth was weakly associated with a decreased risk. CONCLUSIONS: The increased risk of ACPA-negative RA in parous women of reproductive age seemed to be associated with an increased postpartum risk and with young age at first birth. Further research is needed to explore the biological mechanisms behind our findings.
OBJECTIVE: To study the impact of parity history on the risk of antibodies to citrullinated peptide antigens (ACPA) positive and ACPA-negative rheumatoid arthritis (RA), in different age-groups. METHOD: Data from a population-based case-control study of female incident RA cases were analysed (2035 cases and 2911 controls, aged 18-70 years ). Parity history was assessed through a questionnaire. Parous women were compared with nulliparous, by calculating odds ratios (ORs) with 95% confidence interval (CI). RESULTS: Parity was associated with an increased risk of ACPA-negative RA in women aged 18-44 years (OR=2.1, 95% CI 1.4 to 3.2), but not in those aged 45-70 years (OR=0.9, 95% CI 0.7 to 1.3). Among young women, an increased risk of ACPA-negative RA was found in those who gave birth during the year of symptom onset (OR=2.6, 95% CI 1.4 to 4.8) and who were at a young age at first birth (<23) (OR=2.5, 95% CI 1.5 to 4.1). Parity and the postpartum period were not associated with ACPA-positive RA, but older age at first birth was weakly associated with a decreased risk. CONCLUSIONS: The increased risk of ACPA-negative RA in parous women of reproductive age seemed to be associated with an increased postpartum risk and with young age at first birth. Further research is needed to explore the biological mechanisms behind our findings.
Authors: J Rönnelid; M C Wick; J Lampa; S Lindblad; B Nordmark; L Klareskog; R F van Vollenhoven Journal: Ann Rheum Dis Date: 2005-04-20 Impact factor: 19.103
Authors: M Wallenius; J F Skomsvoll; L M Irgens; K A Salvesen; W Koldingsnes; K Mikkelsen; C Kaufmann; T K Kvien Journal: Ann Rheum Dis Date: 2009-08-27 Impact factor: 19.103
Authors: Jeffrey A Sparks; Chia-Yen Chen; Xia Jiang; Johan Askling; Linda T Hiraki; Susan Malspeis; Lars Klareskog; Lars Alfredsson; Karen H Costenbader; Elizabeth W Karlson Journal: Ann Rheum Dis Date: 2014-03-31 Impact factor: 19.103
Authors: Camilla Bengtsson; Susan Malspeis; Cecilia Orellana; Jeffrey A Sparks; Karen H Costenbader; Elizabeth W Karlson Journal: Arthritis Care Res (Hoboken) Date: 2017-09-21 Impact factor: 4.794
Authors: Kevin D Deane; M Kristen Demoruelle; Lindsay B Kelmenson; Kristine A Kuhn; Jill M Norris; V Michael Holers Journal: Best Pract Res Clin Rheumatol Date: 2017-09-18 Impact factor: 4.098
Authors: Tiffany D Pan; Beth A Mueller; Carin E Dugowson; Michael L Richardson; J Lee Nelson Journal: Semin Arthritis Rheum Date: 2019-06-18 Impact factor: 5.532
Authors: Jeffrey A Sparks; Shun-Chiao Chang; Kevin D Deane; Ryan W Gan; M Kristen Demoruelle; Marie L Feser; LauraKay Moss; Jane H Buckner; Richard M Keating; Karen H Costenbader; Peter K Gregersen; Michael H Weisman; Ted R Mikuls; James R O'Dell; V Michael Holers; Jill M Norris; Elizabeth W Karlson Journal: Arthritis Rheumatol Date: 2016-08 Impact factor: 10.995
Authors: Chun Lai Too; Nor Asiah Muhamad; Anna Ilar; Leonid Padyukov; Lars Alfredsson; Lars Klareskog; Shahnaz Murad; Camilla Bengtsson Journal: Ann Rheum Dis Date: 2015-12-17 Impact factor: 19.103
Authors: Mitra Pikwer; Cecilia Orellana; Henrik Källberg; Andreas Pikwer; Carl Turesson; Lars Klareskog; Lars Alfredsson; Saedis Saevarsdottir; Camilla Bengtsson Journal: Arthritis Res Ther Date: 2015-12-12 Impact factor: 5.156